<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABC</journal-id><journal-title-group><journal-title>Advances in Biological Chemistry</journal-title></journal-title-group><issn pub-type="epub">2162-2183</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abc.2020.103006</article-id><article-id pub-id-type="publisher-id">ABC-100699</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Syntheses of Coordination Compounds of 2-Amino-3-Methylbutanoic Acid Their Mixed Ligand Complexes and Antibacterial Activities
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Temitayo</surname><given-names>O. Aiyelabola</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Iyanuoluwa</surname><given-names>E. Okunade</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Johan</surname><given-names>H. L. Jordaan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daniel</surname><given-names>P. Otto</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Research Focus Area for Chemical Resource Beneficiation, Laboratory for Analytical Services; North-West University, Potchefstroom, South Africa</addr-line></aff><aff id="aff1"><addr-line>Department of Chemistry, Obafemi Awolowo University Ile-Ife, Osun State, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>06</month><year>2020</year></pub-date><volume>10</volume><issue>03</issue><fpage>67</fpage><lpage>85</lpage><history><date date-type="received"><day>20,</day>	<month>March</month>	<year>2020</year></date><date date-type="rev-recd"><day>1,</day>	<month>June</month>	<year>2020</year>	</date><date date-type="accepted"><day>4,</day>	<month>June</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Coordination compounds of 2-amino-3-methylbutanoic acid were synthesized with chromium(III) and oxovanadium(IV) ions. M:L; 1:2. Adducts of these complexes using 1,10-phenantroline and ethylenediamine were further synthesized, M:L, (1:2). These compounds were characterized using electronic, infra-red spectrophotometry, magnetic susceptibility measurement and percentage metal analyses. The zones of inhibition and minimum inhibitory concentrations of the compounds against eight microbes were studied. The results obtained indicated an octahedral geometry for the Cr(III) complexes, indicative of additional coordination of two water molecules. On the other hand a square pyramid geometry was obtained for the binary oxovanadium complex and its 1,10-phenantroline adduct. However
  ,
   for the oxovanadium ethylenediamine adduct a distorted octahedral geometry was proposed. The result for the antibacterial studies indicated that both mixed ligand complexes of 1,10-phenantroline exhibited good antibacterial activity, and in some cases better activity than the standard, streptomycin.
 
</p></abstract><kwd-group><kwd>Coordination Compounds</kwd><kwd> 2-Amino-3-Methylbutanoic Acid</kwd><kwd> Mixed Ligand Complexes</kwd><kwd> Minimum Inhibitory Concentration</kwd><kwd> 1</kwd><kwd>10-Phenantroline</kwd><kwd> Ethylenediamine</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>As a result of the vast diversity of transition metal coordination chemistry, prospects for the design of coordination compounds in more recent times have been a subject of great interest [<xref ref-type="bibr" rid="scirp.100699-ref1">1</xref>]. The pharmacological activity of these metal compounds depends on the metal ion, ligands and the structure of the compounds. These factors are partly responsible for the ability of these coordination compounds, to locate the proper target site of activity and as a consequence their pharmacological activity [<xref ref-type="bibr" rid="scirp.100699-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref4">4</xref>]. It is known that certain metal ions penetrate through bacteria cell walls, in the form of complexes, into the cell and inactivate certain enzymes, thus killing such bacteria [<xref ref-type="bibr" rid="scirp.100699-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref6">6</xref>]. Furthermore, prior reports have also indicated that the efficacies of various therapeutic agents are often enhanced upon coordination with a suitable metal ion [<xref ref-type="bibr" rid="scirp.100699-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>].</p><p>A class of coordination compounds being more studied in recent times is the mixed ligand complexes. These complexes have at least two different ligands coordinated to a metal ion [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref12">12</xref>]. The pharmacological activity of these mixed ligand complexes is highly dependent on the nature of the metal ions and the donor sequence of the ligands. This is because different ligands exhibit different structural and biological properties [<xref ref-type="bibr" rid="scirp.100699-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref14">14</xref>]. Their increased activity may be ascribed to a synergistic or additive activity of the differing ligands on the metal ion and the complex as a whole, thereby enhancing the activity of the complex [<xref ref-type="bibr" rid="scirp.100699-ref13">13</xref>]. Moreover, they may have the potential to thwart drug resistance [<xref ref-type="bibr" rid="scirp.100699-ref14">14</xref>]. They also have the potential for increased broad spectrum of activity [<xref ref-type="bibr" rid="scirp.100699-ref15">15</xref>]. A versatile ligand often used in the syntheses of mixed ligand complexes is 1,10-phenantroline, it is a heterocyclic organic compound. It is rigid and its insertion within cyclic and acyclic structures can impact to the resulting complex a high degree of pre-organization [<xref ref-type="bibr" rid="scirp.100699-ref16">16</xref>]. The antimicrobial activity of 1,10-phenantroline is also well established [<xref ref-type="bibr" rid="scirp.100699-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref18">18</xref>]. Ethylenediamine is also another well known ligand used in coordination chemistry. Reports have shown that numerous bio-active compounds and drugs contain the N–CH<sub>2</sub>–CH<sub>2</sub>–N linkage, which exists in ethylenediamine [<xref ref-type="bibr" rid="scirp.100699-ref19">19</xref>].</p><p>In spite of a huge number of antibiotics and chemotherapeutics available for medical use, there is still an outbreak of diseases caused by different pathogenic bacteria and the development of resistance to antibiotics [<xref ref-type="bibr" rid="scirp.100699-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref14">14</xref>]. Researchers are as a consequence searching for new antibacterial agents. Furthermore, earlier studies have also shown that some coordination compounds of biologically important compounds such as amino acids exhibited promising antimicrobial activities on chelation [<xref ref-type="bibr" rid="scirp.100699-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref21">21</xref>]. As a result of the probable enhanced antibacterial activity of mixed ligand complexes it was therefore considered to synthesize coordination compounds of 2-amino-3-methylbutanoic acid (<xref ref-type="fig" rid="fig1">Figure 1</xref>) with chromium(III) and oxovanadium(IV). Their mixed ligand complexes with 1,10-phenantroline and ethylenediamine (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>), M:L1:L2 and M:L1:L3 metal ligand ratio (1:1:1) (where M= Cr(III) or VO(IV), L1 = 2-amino-3-methylbutanoic acid, L2 = 1,10-phenantroline, L3 = ethylenediamine) were also synthesized. These compounds were characterized using infra-red, electronic and atomic absorption spectroscopy and magnetic susceptibility measurement. The antibacterial assays of the synthesized compounds was carried out</p><p>using disc diffusion agar method to determine their zones of inhibitions against eight microbes; three gram positive and five gram negative bacteria. The minimum inhibition concentrations of the more active compounds were also obtained.</p></sec><sec id="s2"><title>2. Materials and Method</title><sec id="s2_1"><title>2.1. General</title><p>All materials used are of high analytical grade. Melting points were determined in an open capillary tube on a Gallenkamp (Variable heater) melting point apparatus. The infrared spectra of all synthesized product and their ligands were obtained at the Centre for Energy Research and Development Obafemi Awolowo University Ile-Ife, Osun State. Magnetic susceptibility measurement of the metal complexes was obtained at the Department of Chemistry, Kwara State University Ilorin, Nigeria. The electronic spectra, of all the compounds, were obtained in solution, in the wavelength range 400 - 1000 nm at the Department of Chemistry, Obafemi Awolowo University, Ile-Ife, Osun State Nigeria. The metal analyses for all synthesized compounds were obtained using atomic absorption spectroscopy at the Centre for Energy Research and Development Obafemi Awolowo University Ile-Ife, Osun state. The antimicrobial screening for all the complexes was carried out in the Department of Microbiology at Obafemi Awolowo University Ile Ife, Osun state. Nigeria.</p><p>The equations of the reactions are given in Equations (1)-(6).</p><p>CrCl<sub>3</sub> + 2(L1) → [(Cr(L1)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>] (Compound 1) (1)</p><p>CrCl<sub>3</sub> + L1+ L2 → [Co(L1)(L2)(H<sub>2</sub>O)<sub>2</sub>] (Compound 2) (2)</p><p>CrCl<sub>3</sub> + L1+ L3 → [Co(L1)(L3)(H<sub>2</sub>O)<sub>2</sub>] (Compound 3) (3)</p><p>VOSO<sub>4</sub> +2(L1) → VO(L1)<sub>2</sub>] (Compound 4) (4)</p><p>VOSO<sub>4</sub> + L1 + L2 → VO(L1)(L2)] (Compound 5) (5)</p><p>VOSO<sub>4</sub> + L1 + L3 → VO(L1)(L3)(H<sub>2</sub>O)] Compound 6) (6)</p><p>where: L1 = 2-amino-3-methylbutanoic acid</p><p>L2 = 1,10-phenantroline; L3 = ethylenediamine.</p></sec><sec id="s2_2"><title>2.2. Syntheses of Compounds</title><sec id="s2_2_1"><title>2.2.1. Synthesis of Compound 1</title><p>An aqueous solution of chromium(III) chloride hexahydrate (1.59 g, 0.01 M) was poured into a flat bottom flack and was heated with stirring. To this was added, drop-wise, an aqueous ethanolic solution of 2-amino-3-methylbutanoic acid (2.36 g, 0.02 M). The reaction mixture was heated for 2 h, during which a pink precipitate was obtained. This was filtered washed first with methanol then diethyl ether and dried in a desiccator.</p><p>Similar procedure was used for the preparation of the under listed complexes.</p></sec><sec id="s2_2_2"><title>2.2.2. Synthesis of Compound 2</title><p>Chromium(III) chloride hexahydrate (1.58 g, 0.01 M) in a flat bottom flask to which was added 2-amino-3-methylbutanoic acid (1.18 g; 0.01 M) and 1,10-phenantroline (1.80 g, 0.01 M) heated with stirring. This gave a dark green precipitate.</p></sec><sec id="s2_2_3"><title>2.2.3. Synthesis of Compound 3</title><p>Chromium(III) chloride hexahydrate (1.61 g, 0.01 M) to which 2-amino-3-methylbutanoic acid (1.32 g; 0.01 M) and ethane-1,2-diamine monohydrate (0.78 g, 0.01M) was added and heated with stirring. This gave a light pink precipitate.</p></sec><sec id="s2_2_4"><title>2.2.4. Synthesis of Compound 4</title><p>Vanadium(IV) oxide sulphate (1.63 g, 0.01 M) and 2-amino-3-methylbutanoic acid (2.38 g; 0.02 M) gave a pink precipitate.</p></sec><sec id="s2_2_5"><title>2.2.5. Synthesis of Compound 5</title><p>Vanadyl sulphate (1.63 g, 0.01 M) to which was added 2-amino-3-methylbutanoic acid (1.32 g; 0.01 M) and 1,10-phenantroline (1.83 g, 0.01 M), heated with stirring, gave a grey precipitate.</p></sec><sec id="s2_2_6"><title>2.2.6. Synthesis of Compound 6</title><p>Vanadyl sulphate (1.65 g, 0.01 M), 2-amino-3-methylbutanoic acid (1.34 g; 0.01 M) and ethylenediamine monohydrate (0.79 g, 0.01 M), gave a grey precipitate.</p></sec></sec><sec id="s2_3"><title>2.3. Antimicrobial Methodology</title><sec id="s2_3_1"><title>2.3.1. Zones of Inhibition</title><p>The organisms used were three Gram-positive and five Gram-negative bacteria. The agents were dissolved in water at room temperature or hot water as appropriate to give a concentration of 40 mg/mL. The resulting solutions were used to soak sterile Whatman No 2 discs (diameter of 6 mm) and allowed to dry in an oven at 50˚C. The discs were then utilized to determine antibacterial as previously described by Aiyelabola et al. 2012 [<xref ref-type="bibr" rid="scirp.100699-ref22">22</xref>]. Discs that were impregnated with streptomycin were used as positive controls for bacteria. Zones of inhibition were used as indices of antimicrobial actions.</p></sec><sec id="s2_3_2"><title>2.3.2. Minimum Inhibitory Concentration Determination</title><p>The determination of the minimal inhibitory concentration (MIC) for the antibacterial activities of three of the compounds and standard drugs were evaluated using the microdilution method, using an adaptation of the methodology as described by Pasdar, H and co-worker, 2017 [<xref ref-type="bibr" rid="scirp.100699-ref23">23</xref>]. Each test compound and standard drug individually was prepared in aqueous ethanol to obtain 10 &#181;g/mL concentrations (stock solution). The aim of the broth micro-dilution method was the evaluation of the lowest concentration of the examined antibacterial agent to inhibit the visible growth of the microorganism being investigated. Muller–Hinton Broths (MHB) was used as bacterial nutrients. The inoculum size of all strains was adjusted to 1.5 &#215; 10<sup>8</sup> CFU/mL using 0.5 McFarland standard solutions for each antibacterial compound and standard drug (streptomycin). Fifteen tubes of 5 mL volume were used in 3 rows such that each row contained 5 tubes. Afterwards, 1 mL of Muller–Hinton Broth (for Row 1 and 2) and 1 mL of standard drug broth (for row 3) were added in Tubes 1 - 5 in each row. Then, 1 mL of the antibacterial compound (stock solution) was added to the ﬁrst tube in each row (for Row 1 and 2) and mixed. After mixing, 1 mL of the ﬁrst tube in each row was serially carried over to the second tube in the same row, mixed and the content of the second tube was transferred to the third tube in each row. This serial dilution was repeated to Tube 4 in each of the rows and 1 mL of Tube 4 was discarded. Tube 4 had no bacteria and was used as a negative control. Tube 5, without antibacterial agent, was used as a positive control. Thus, the micro-dilution provided antibacterial concentrations of 5, 2.5, 1.75 and 0.875 &#181;g/mL respectively. Finally, 100 &#181;L of bacteria suspension was added to Tubes 1 - 3 and 5 in Rows 1 - 3 and were incubated for 24 h at 37 <sup>◦</sup>C. The highest dilution of active sample to inhibit evident growth of the microorganism was expressed as the MIC [<xref ref-type="bibr" rid="scirp.100699-ref23">23</xref>].</p></sec></sec></sec><sec id="s3"><title>3. Result and Discussion</title><sec id="s3_1"><title>3.1. Physico-Chemical Properties</title><p>The colour, percentage yield, percentage metal and melting points of the synthesized compounds are presented in <xref ref-type="table" rid="table1">Table 1</xref>. The compounds showed a wide variety of colour from pink to grey. The compounds were obtained at good yield. Sharp melting points were obtained for the compounds suggesting the purity of the compounds. The compounds were fairly soluble in ethanol/water mixture and insoluble in most organic solvents. The percentage analysis for the compounds was obtained using atomic absorption spectroscopy/titremetric method. The results obtained are in good agreement with the calculated values; as</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Some Physico-chemical Properties of the ligands and complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compound</th><th align="center" valign="middle" >Proposed mol. Formula</th><th align="center" valign="middle" >Proposed m.wt</th><th align="center" valign="middle" >Colour</th><th align="center" valign="middle" >%yield</th><th align="center" valign="middle" >Mp/d.t ˚C</th><th align="center" valign="middle" >Magnetic moment (BM)</th><th align="center" valign="middle" >%metal Found (Cal.)</th></tr></thead><tr><td align="center" valign="middle" >L1<sup> </sup> L2 L3 1 2 3 4 5 6</td><td align="center" valign="middle" >C<sub>5</sub>H<sub>11</sub>NO<sub>2 </sub> C<sub>12</sub>H<sub>8</sub>N<sub>2</sub> C<sub>2</sub>H<sub>8</sub>N<sub>2 </sub> [(Cr(L1)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]Cl [Co(L1)(L2)(H<sub>2</sub>O)<sub>2</sub>]Cl<sub>2 </sub> [Co(L1)(L3)(H<sub>2</sub>O)<sub>2</sub>]Cl<sub>2 </sub> VO(L1)<sub>2</sub>] [VO(L1)(L2)]<sub>2</sub>SO<sub>4</sub> [VO(L1)(L3)(H<sub>2</sub>O)]<sub>2</sub>SO<sub>4 </sub></td><td align="center" valign="middle" >117.15 180.21 60.00 353.80 455.20 335.00 297.00 822.42 618.00</td><td align="center" valign="middle" >White White Colourless Pink Deep green Light pink Pink Gray Gray</td><td align="center" valign="middle" >NA NA NA 61.4 72.3 77.1 69.2 76.4 73.6</td><td align="center" valign="middle" >298 117 NA 270 269 274 284 285 306</td><td align="center" valign="middle" >NA NA NA 3.14 3.84 3.84 1.75 1.97 2.05</td><td align="center" valign="middle" >NA NA NA 15.20 (14.77) 11.87 (11.42) 15.44 (15.52) 17.45 (17.17) 12.54 (12.40) 8.67 (8.31)</td></tr></tbody></table></table-wrap><p>such the results obtained corroborated the proposed composition of the compounds.</p></sec><sec id="s3_2"><title>3.2. Infra-Red</title><sec id="s3_2_1"><title>3.2.1. Ligand</title><p>1) 2-amino-3-methylbutanoic acid: The spectrum of 2-amino-3-methylbutanoic acid exhibited characteristic vibrational frequency bands such as the ν(N–H) of the cationic NH+ 3 ion observed at 3400 cm<sup>−1</sup> (<xref ref-type="table" rid="table2">Table 2</xref>). The spectrum further displayed bands at 1607 cm<sup>−1</sup> and 1495 cm<sup>−1</sup> which are consistent with the asymmetric and symmetric COO<sup>−</sup> stretching frequencies and both are typical vibrational frequencies of 2-amino-3-methylbutanoic acid [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>].</p><p>2) 1,10-phenantroline: The spectrum for this compound elicited a band at 1588 cm<sup>−1</sup> assignable to the ν(C=N) [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>].</p><p>3) Ethylenediamine: The infrared spectrum revealed a band at 3373 cm<sup>−1</sup> which was ascribed to the ν(N–H) of the amine substituent of the ligand. Two other sharp bands were also observed at 1567 and 1403 cm<sup>−1</sup>, <xref ref-type="table" rid="table2">Table 2</xref> and are ascribed to ν(C–C–N) and ν(C–N) of C–C–NH<sub>2</sub> bond vibration [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>].</p></sec><sec id="s3_2_2"><title>3.2.2. Complexes</title><p>Chromium complexes</p><p>1) Compound 1: A shift was observed to higher wave number for the ν(N–H) symmetric stretching frequency thus suggestive of deprotonation and hence coordination of the nitrogen atom of the amino moiety to the metal ion. This was supported by the M–N stretching frequency observed at 612 cm<sup>−1</sup> [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. On the other-hand a shift was observed to higher wave number for the COO<sup>−</sup> symmetric stretching frequency and a shift to lower wave number for the ν<sub>asym</sub>(COO<sup>−</sup>) by (80) cm<sup>−1</sup>. Previous reports have suggested that this indicates coordination of the ligand to the metal ion. A difference of 219 cm<sup>−1</sup> exists between both the ν<sub>sym</sub>(COO<sup>−</sup>) and ν<sub>asym</sub>(COO<sup>−</sup>) thus indicating the monodentate nature of the COO<sup>−</sup> substituent of the ligand in this complex. Corroborating the coordination via the oxygen atom is the M–O band observed at 580 cm<sup>−1</sup>. Furthermore, evidence for the coordination of water molecule to the metal ion was provided by the bands observed at 2587, 1033 and 810 cm<sup>−1</sup> assignable to ν(C−OH), ν(C–O) and ν(C–O) bending and rocking vibrational frequencies [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>].</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Relevant infrared spectra bands for the ligands and complexes (cm<sup>−1</sup>)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compound</th><th align="center" valign="middle" >NH</th><th align="center" valign="middle" >COO</th><th align="center" valign="middle" >COO</th><th align="center" valign="middle" >C=N</th><th align="center" valign="middle" >M-N</th><th align="center" valign="middle" >M-O</th></tr></thead><tr><td align="center" valign="middle" >L1 L2 L3 1 2 3 4 5 6</td><td align="center" valign="middle" >3400 - 3373 3424 3362 3390 3481 3444 3365</td><td align="center" valign="middle" >1607 - 1567 1634 1635 1638 1653 1635 1639</td><td align="center" valign="middle" >1495 - 1403 1415 1398 1411 1455 1399 1400</td><td align="center" valign="middle" >- 1588 - - 1506 - - 1504 -</td><td align="center" valign="middle" >- - - 612 562 632 647 615 672</td><td align="center" valign="middle" >- - - 580 536 570 537 568</td></tr></tbody></table></table-wrap><p>2) Compound 2: Evidence for coordination of the 2-amino-3-methylbutanoic acid in this mixed ligand complex was provided by the ν(N–H), ν<sub>sym</sub>(COO) and ν<sub>asym</sub>(COO) bands observed at 3362, 1635 and 1398 cm<sup>−1</sup> respectively. Support for the formation of the mixed ligand and hence coordination of 1,10-phenantroline was observed by the shift in the ν(C=N), 82 cm<sup>−1</sup> in comparison to that of the ligand, it should be noted that this was absent in the spectrum of 2-amino-3-methylbutanoic acid [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. Absorption frequencies observed at 1032 and 1015 and attributable to ν(C–O) suggest coordination of water to the metal ion [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref27">27</xref>].</p><p>3) Compound 3: For this mixed ligand complex evidence for coordination of the 2-amino-3-methylbutanoic acid was observed in the shift of the ν(N–H), ν<sub>sym</sub>(COO) and ν<sub>asym</sub>(COO). This were further corroborated by the ν(M–N), ν(M–O) bands [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. The band observed at 1325 cm<sup>−1</sup> was assigned to the ν(C– C–N) of C–C–NH<sub>2</sub> from ethylenediame. This indicated a shift of 95 cm<sup>−1</sup> on coordination, thus indicative of coordination of the metal ion to the ligand. Additional coordination by water molecule was suggested by the appearance of the ν(C–O) band and ν(M–O) [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref27">27</xref>].</p></sec><sec id="s3_2_3"><title>3.2.3. Vanadium Complexes</title><p>1) Compound 4: Similar to the bis(2-amino-3-methylbutanoic acid)chromium (III) complex, a shift to high frequency was observed for the ν(N–H) stretching frequency by 81 cm<sup>−1</sup> [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. As such, this suggested the coordination of the nitrogen atom of the ligand to the metal ion. This was further supported by the ν(M–N) observed at 637 cm<sup>−1</sup>. The spectrum also showed two sharp bands at 1653 and 1455 cm<sup>−1</sup>, which are assignable to characteristic ν<sub>sym</sub>(COO<sup>−</sup>) and ν<sub>asym</sub>(COO<sup>−</sup>) of the ligand. This indicated a shift in comparison to those of the free ligand. The difference of 197 cm<sup>−1</sup> between both band frequencies suggests the monodentate nature of the ligand in this complex [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. Coordination of the oxygen atom of the carboxylate ion was also supported by the ν(M–O) at 570 cm<sup>−1</sup>. A band observed at 950 cm<sup>−1</sup> was attributed to ν(V=O), suggestive of the monomeric nature of the complex [<xref ref-type="bibr" rid="scirp.100699-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref30">30</xref>].</p><p>2) Compound 5: This spectrum exhibited a band at 3444 cm<sup>−1</sup> ascribable to ν(N-H) of the amino substituent of 2-amino-3-methylbutanoic acid. Thus, suggesting coordination of the metal ion with the primary ligand, 2-amino-3-methylbutanoic acid. Coordination of the secondary ligand 1,10-phenantroline to the metal ion was suggested by the band observed at 1504 cm<sup>−1</sup> attributable to C=N stretching frequency of 1,10-phenantroline [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. This indicated a shift by 84 cm<sup>−1</sup> to higher wave number in relation with the free base. As such this serves to establish the formation of the mixed ligand complex. The band observed at 986 cm<sup>−1</sup>, assigned to ν(V=O) is indicative of the monomeric nature of the complex [<xref ref-type="bibr" rid="scirp.100699-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref30">30</xref>].</p><p>3) Compound 6: The ν(N−H) of the primary ligand was observed at 3365 cm<sup>−1</sup>. A broad band in the shape of a trough appeared at 2100 cm<sup>−1</sup> and was attributed to the ν(C−OH). This therefore, suggests coordination of a water molecule. Bands at 1639 and 1400cm<sup>−1</sup> were assigned to ν<sub>sym</sub>(COO<sup>−</sup>) and ν<sub>asym</sub>(COO<sup>−</sup>) of the ligand, 2-amino-3-methylbutanoic acid [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. A sharp band at 1390 cm<sup>−1</sup> corresponds to the ν(C–C–N) of C–C–NH<sub>2</sub> bond vibration, of the secondary ligand. Two medium bands observed at 1230 and 1120 cm<sup>−1</sup> were assigned to the ν(C−N) of both the primary and secondary ligand [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. The ν(M−O) was observed at 672 and 612 cm<sup>−1</sup>, thus, supportive of coordination of the oxygen atom from the carboxylate substituent of the primary ligand and also coordination a water molecule to the metal ion [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. A weak band observed at the low energy region of the spectrum at 520 cm<sup>−1</sup> was assigned to the ν(M−N). This thus confirms the coordination of the nitrogen atom of the primary ligand to the metal ion. However the ν(V=O) band was absent. According to Greenwood and Earnshaw, a sixth ligand may be weakly bonded trans to the (V=O) moiety and thus produce a distorted octahedral structure; with a concomitant reduction in the stretching frequency of the (V=O) bond. This they suggested may be interpreted in terms of electron donation from this sixth bond, thereby making the vanadium atom less able to accept charge from the oxygen of (V=O) and so reducing the bond order. Additionally previous reports have shown similar complexes to be polymeric, with the vanadium ion attaining 6-coordination by stacking, so that the sixth position of each vanadium is occupied by the oxygen from the (V=O) beneath [<xref ref-type="bibr" rid="scirp.100699-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref30">30</xref>].</p></sec></sec><sec id="s3_3"><title>3.3. Electronic Spectrum and Magnetic Moment</title><sec id="s3_3_1"><title>3.3.1. Ligand</title><p>The electronic spectra of the ligands exhibited bands in the ultraviolent region of the electromagnetic spectrum as a result of the major chromophores which exists on the ligands, <xref ref-type="table" rid="table3">Table 3</xref>. The spectrum of 2-amino-3-methylbutanoic acid elicited a band at 252 nm and was assigned to n → π* transition. The spectrum of 1,10-phenantroline showed two intense bands 310 and 324 nm which corresponds to n → π* and π → π* transitions [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>]. For ethylenediamine the spectrum revealed a band at 495 nm attributable to n → σ* transition [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>]. Evidence of coordination of the metal ion with the corresponding ligands was provided by the d-d transitions of the metal ion observed in the complexes, which were absent in the ligands. Further corroborating coordination of the ligands</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Relevant electronic spectra bands</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compound</th><th align="center" valign="middle" >Intraligand Band (nm)</th><th align="center" valign="middle" >d-d bands (nm)</th></tr></thead><tr><td align="center" valign="middle" >L1 L2 L3 1 2 3 4 5 6</td><td align="center" valign="middle" >252 310, 324 495 302 286 413 295, 359 267, 285 295, 450</td><td align="center" valign="middle" >- - - 465, 505, 695 435 480 650, 712 518, 720 580, 716</td></tr></tbody></table></table-wrap><p>to the metal ions were shifts observed in the bands observed in the ultraviolet region of the spectra of the coordination compounds in relation to that obtained for the free base [<xref ref-type="bibr" rid="scirp.100699-ref28">28</xref>].</p></sec><sec id="s3_3_2"><title>3.3.2. Chromium Complexes</title><p>1) Compound 1: The electronic spectrum of this compound exhibited two sets of bands: a strong band at 302 nm; one weak band at 465 nm, two broad bands at 505 and 695 nm. The strong band in the ultraviolet region was ascribed to the n → π* transition of the ligand. This thus indicated a shift in this transition in comparison with the free base, 2-amino-3-methylbutanoic acid. On the other hand the other three bands were attributed to the <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>1g</sub>(P), <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>1g</sub>(F) and <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>2g</sub>(F) transitions characteristic of d<sup>3</sup> Cr(III) configuration, suggestive of an octahedral geometry. This is in agreement with previous studies [<xref ref-type="bibr" rid="scirp.100699-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>]. The observed magnetic moment at 3.14 BM is close to the spin only magnetic moment for Cr(III) with d<sup>3</sup> configuration, but lower than that expected for this configuration [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>]. This may be ascribed to antiferromagnetism, suggesting that the Cr(III) ion has its spins aligned in opposite directions [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>]. Compound 1: The electronic spectrum of this compound exhibited two sets of bands: a strong band at 302 nm; one weak band at 465 nm, two broad bands at 505 and 695 nm. The strong band in the ultraviolet region was ascribed to the n → π* transition of the ligand. This thus indicated a shift in this transition in comparison with the free base, 2-amino-3-methylbutanoic acid. On the other hand the other three bands were attributed to the <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>1g</sub>(P), <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>1g</sub>(F) and <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>2g</sub>(F) transitions characteristic of d<sup>3</sup> Cr(III) configuration, suggestive of an octahedral geometry. This is in agreement with previous studies [<xref ref-type="bibr" rid="scirp.100699-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>]. The observed magnetic moment at 3.14 BM is close to the spin only magnetic moment for Cr(III) with d<sup>3</sup> configuration, but lower than that expected for this configuration [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>]. This may be ascribed to antiferromagnetism, suggesting that the Cr(III) ion has its spins aligned in opposite directions [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>].</p><p>2) Compound 2: The spectrum of this compound elicited two bands, one intense band at 286 nm assigned to n → π* transition and a broad band at 435 nm attributable to the d-d transition of the metal ion and ascribed to <sup>4</sup>A<sub>2g</sub>(F) → <sup>4</sup>T<sub>1g</sub>(F) transition, suggestive of an octahedral geometry [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>]. Its magnetic moment 3.84 BM, is consistent with the spin-only magnetic moment of 3.87 BM for an octahedral geometry for a d<sup>3</sup> electron configuration system. It therefore corroborates an octahedral geometry for compound 2 [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>].</p><p>3) Compound 3: Similar to that of compound 2, two bands were also observed for this complex at 413 and 480 nm. These were assigned to π → π* intra-ligand transition and <sup>4</sup>A<sub>2g</sub>→ <sup>4</sup>T<sub>1g</sub>(F), d-d transition respectively [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref33">33</xref>], thus suggestive of an octahedral geometry for Cr(III) ion. Its magnetic moment of 3.84 BM further supports an octahedral geometry [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>].</p></sec><sec id="s3_3_3"><title>3.3.3. Oxovanadium Complexes</title><p>1) Compound 4: The electronic spectrum of compound 4, exhibited four bands. Two intense bands were observed at 295 and 359 nm and were assignable to n → π* and π → π* intra-ligand transitions. It also showed two broad bands at 650 and 712 nm ascribed to <sup>2</sup>B<sub>2</sub> → <sup>2</sup>E and <sup>2</sup>B<sub>2</sub> → <sup>2</sup>B<sub>1</sub>, d-d transitions [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>]. According to previous reports this indicates a square pyramidal geometry. Its magnetic moment of 1.75 BM is characteristic of a square pyramid geometry for V(IV) ion. This is therefore corroborates of a square pyramid geometry for compound 4.</p><p>2) Compound 5: The spectrum of this compound displayed five bands. Two intense band and a medium band observed at 267, 285, 315 nm respectively, and they are attributed to n → σ*, n → π* and π → π* intra-ligand transitions of the ligands [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>]. The spectrum also exhibited two broad bands, at 518 and 720 nm; this is ascribable to <sup>2</sup>B<sub>2</sub> → <sup>2</sup>E and <sup>2</sup>B<sub>2</sub> → <sup>2</sup>B<sub>1</sub> d-d transitions [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>]. This corresponds to a square pyramid geometry for VO(IV) ion. A magnetic moment of 1.97 BM was obtained for compound 5, this is slightly higher than the spin only value of 1.73 BM. And is consistent with a d<sup>1</sup> electron configuration for vanadium(IV). The increment in the magnetic moment may however be ascribed to orbital contribution [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref36">36</xref>]. Furthermore prior workers on oxovanadium(IV) ion have interpreted this magnetic moment to be suggestive of a square pyramid geometry around the oxovanadium(IV) ion. Therefore a square pyramidal geometry is proposed for compound 5.</p><p>3) Compound 6: The spectrum of this complex displayed three bands: an intense band at 295 nm and two medium bands at 387 and 450 nm, which were assigned to n → π*, n → σ* and π → π* intraligand transitions respectively [<xref ref-type="bibr" rid="scirp.100699-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref25">25</xref>]. The spectrum also exhibited two broad bands at 580 and 716 nm corresponding to <sup>2</sup>B<sub>2</sub> → <sup>2</sup>E and <sup>2</sup>B<sub>2</sub> → <sup>2</sup>B<sub>1</sub> d-d transitions, for vanadium(IV) [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>]. A magnetic moment of 2.03 BM was obtained for this compound. This is higher than the spin only value of 1.73 BM. However, earlier workers have interpreted this to be consistent with an octahedral geometry for vanadium(IV) ion. We propose therefore an octahedral geometry for this compound [<xref ref-type="bibr" rid="scirp.100699-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref35">35</xref>]. This is in good agreement with the result obtained for this compound from the infrared analysis.</p><p>In this present work, based on the results obtained an octahedral geometry is proposed for the Cr(III) complex for the binary complex, bis(2-amino-3-methylbutanoic acid)chromium(III) complex. It is suggested that the 2-amino-3-methylbutanoic acid free base coordinated via the nitrogen atom of the amino substituent and one oxygen atom of the carboxylate ion. This was suggested as a result of the difference observed in the values for ν<sub>sym</sub>(COO<sup>−</sup>) and ν<sub>asym</sub>(COO<sup>−</sup>), which suggested the monodentate nature of the carboxylate substituent of the ligand [<xref ref-type="bibr" rid="scirp.100699-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref26">26</xref>]. This is also in good agreement with previous reports. These results thus indicated that 2-amino-3-methylbutanoic acid coordinated in a bidentate fashion, binding in the ratio 1:2, metal ligand ratio. We propose further that the central Cr(III) ion coordinated additionally to two water molecules from the reaction solvent, to achieve an octahedral geometry. For the formation of the mixed ligand chromium(III) complexes, the primary ligand, 2-amino-3-methylbutanoic acid, coordinated in a similar way as in the binary complex. On the other hand, both secondary ligands coordinated in a bidentate manner with 1,10-phenantroline coordinating via the two heteroaromatic nitrogen atoms and ethylenediamine forming the complex using the two nitrogen atoms of the amino moiety. Similar to the binary Cr(III) complex, the Cr(III) ternary complexes existed in an octahedral geometry, with two additional water molecules coordinated to the Cr(III) ion at the apical region of the complexes. This was further confirmed by the results obtained from the metal analyses of the complexes, <xref ref-type="table" rid="table1">Table 1</xref>. Therefore we propose that the structure assumed by compounds 1 - 3 may be represented by Figures 4-6 respectively. An octahedral geometry is generally more favourable for chromium(III) complexes, as a result of the three electrons in the 3d orbital of Cr(III), these will first singly fill the lower energy three t<sub>2</sub>g orbitals, as a result of the stability of this configuration [<xref ref-type="bibr" rid="scirp.100699-ref32">32</xref>].</p><p>The results obtained for the oxovadium(IV) complexes suggested that the primary ligand 2-amino-3-methylbutanoic and the secondary ligands 1,10-phenantroline and ethylenediamine coordinated in a similar manner as in the Cr(III) ion. However a square pyramidal monomeric geometry was assumed in the case of compounds 4 and 5. A distorted octahedral geometry was however proposed for compound 6. The percentage metal analyses was corroborative of this geometry</p><p>and suggested the formulations for compound 4 and 5 to be given by VO(L1)<sub>2</sub> and [VO(L1)(L2)]<sub>2</sub>SO<sub>4</sub>, which may be depicted by <xref ref-type="fig" rid="fig7">Figure 7</xref> and <xref ref-type="fig" rid="fig8">Figure 8</xref> respectively. Furthermore compound 6 may be represented by VO(L1)(L3)(H<sub>2</sub>O)]<sub>2</sub>SO<sub>4</sub> and illustrated structurally by <xref ref-type="fig" rid="fig9">Figure 9</xref>.</p></sec></sec><sec id="s3_4"><title>3.4. Antibacterial Activity</title><sec id="s3_4_1"><title>3.4.1. Zones of Inhibition of Bacteria Growth</title><p>The synthesized compounds were tested for their antibactebial activity by testing them against eight microbes, three gram positive bacteria namely: S. aureus (NCIB 8585), B. subtilis (NCIB 6639) and B. cereus (NCIB 6349); five gram negative bacteria, P. aeruginosa (NCIB 950), P. fluorescence (NCIB 3756), E. coli (NCIB 86), K. pneunoniae (NCIB 418) and P. vulgaris (NCIB 67). The zones of inhibition of the tested microbial growth as a result of the synthesized compounds were determined and the results obtained are presented in <xref ref-type="table" rid="table4">Table 4</xref>. The results indicated that compounds 2, 4 and 5 exhibited from weak, moderate to remarkable activity against the tested microbes. Compounds 2 and 5 exhibited significantly better activity, (P &lt; 0.05), against E. coli and K. pneunoniae, both gram negative bacteria, relative to the standard, streptomycin. This result thus</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Result of zone of antimicrobial inhibition (mm) for the ligands and complexes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Organism</th><th align="center" valign="middle" >L1</th><th align="center" valign="middle" >L2</th><th align="center" valign="middle" >L3</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >3</th><th align="center" valign="middle" >4</th><th align="center" valign="middle" >5</th><th align="center" valign="middle" >6</th><th align="center" valign="middle" >C</th></tr></thead><tr><td align="center" valign="middle" >P. aeruginosa P. fluorescence S. aureus B. subtilis E. coli K. pneunoniae P. vulgaris B. cereus</td><td align="center" valign="middle" >- - - - - - - -</td><td align="center" valign="middle" >24 10 34 28 23 32 42 -</td><td align="center" valign="middle" >- - - - - - - -</td><td align="center" valign="middle" >- - - - - - - -</td><td align="center" valign="middle" >04 22 31 - 20 28 39 -</td><td align="center" valign="middle" >- - - - - - - -</td><td align="center" valign="middle" >- - - - 04 - 16 -</td><td align="center" valign="middle" >20 18 24 15 10 34 36 -</td><td align="center" valign="middle" >- - - - - - - -</td><td align="center" valign="middle" >31.5 50 38 34 - 10 62 68</td></tr></tbody></table></table-wrap><p>C = Streptomycin.</p><p>suggests the potency of these compounds and their good candidacy as leads as antibacterial agents against both microbes.</p><p>For the binary complexes, only compound 4 exhibited any activity against the tested microbes. This vanadyl complex exhibited weak activity against E. coli and P. vulgaris, but its chromium(III) counterpart had no effect on the tested organisms. Such better activity of the bis(2-amino-3-methylbutanoic acid)oxovanadium(IV) complex in comparison with its chromium(III) counterpart indicates the better activity of the vanadyl ion as an antibacterial agent in this case. Both mixed ligand complexes of 2-amino-3-methylbutanoic acid with 1,10-phenantroline, also displayed significant activity (P &lt; 0.05), against both gram positive and gram negative bacteria, indicating the broad spectrum of activity of both compounds against the tested microbes. However, both compounds exhibited varied activity with each microbe [<xref ref-type="bibr" rid="scirp.100699-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref37">37</xref>]. Although both mixed ligand complexes of 1,10-phenantroline elicited good antibacterial activities, however both Cr(III) and VO(IV) mixed ligand complex of 2-amino-3-methylbutanoic acid with ethylenediamine had no effect on the tested microbes. This may be ascribed on one hand to the better antibacterial activity of 1,10-phenantroline [<xref ref-type="bibr" rid="scirp.100699-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref17">17</xref>]. It can be inferred from the results obtained that the use of 1,10-phenantroline in the formation of the mixed ligand compounds 2 and 5 brought additive effect of its antibacterial potential on both adducts [<xref ref-type="bibr" rid="scirp.100699-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref17">17</xref>]. On the other hand, structurally 1,10-phenantroline is a hydrophobic heteroaromatic compound, as against ethylenediamine which is a straight chain hetero-compound, as such it may be considered that it may have increased the liposolubility of both adducts and therefore enhanced the penetration of these compounds through the lipid membrane of the gram positive bacteria. Thus, this resulted to the better activity of both compounds, relative to their ethylenediamine counterpart, thereby further validating the antibacterial potency of 1,10-phenantroline and the plausible additive ability of this molecule in enhancing the antibacterial activity of mixed ligand complexes [<xref ref-type="bibr" rid="scirp.100699-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref37">37</xref>].</p><p>The zone of inhibition values obtained for 2-amino-3-methylbutanoic acid are lower than those of compounds 2, 4 and 5 against most of the micro-organisms, indicating that these compounds are more potent than this ligand as antibacterial agent. This observed disparity in their effectiveness against the tested bacteria may be ascribed to either the enhanced ability, as a result of coordination, of these compounds to permeate the cell walls of the microbes or the difference in the ribosomes of the microbial cells [<xref ref-type="bibr" rid="scirp.100699-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref37">37</xref>]. The results obtained, <xref ref-type="table" rid="table4">Table 4</xref>, also indicated that 1,10-phenantroline, one of the secondary ligands, exhibited in some cases significant activity (P &lt; 0.05), against the tested microbes, and in some cases more active than the standard. The most sensitive strains were the bacteria species E. coli and K. pneunoniae. This result is in agreement with what was obtained by Ga&#235;lle and co-workers [<xref ref-type="bibr" rid="scirp.100699-ref38">38</xref>].</p></sec><sec id="s3_4_2"><title>3.4.2. Minimum Inhibitory Concentration</title><p>The antimicrobial activities of some of the complexes were quantified by the</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Result of minimum inhibitory concentration</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Organism</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >4</th><th align="center" valign="middle" >5</th></tr></thead><tr><td align="center" valign="middle" >P. aeruginosa P. fluorescence S. aureus B. subtilis E. coli K. pneunoniae P. vulgaris B. cereus</td><td align="center" valign="middle" >05 2.5 1.75 - 0.875 2.5 2.5 -</td><td align="center" valign="middle" >05 05 05 05 0.875 05 05 05</td><td align="center" valign="middle" >1.78 0.875 0.875 0.875 0.875 0.875 0.875 0.875</td></tr></tbody></table></table-wrap><p>determination of their MICs. The MIC indicates the lowest drug concentration at which a visible inhibition growth of the microorganisms is noticed. The values for the different pathogens were determined by using the micro broth dilution test [<xref ref-type="bibr" rid="scirp.100699-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref38">38</xref>]. The MIC values for compounds 2, 4 and 5 are presented in <xref ref-type="table" rid="table5">Table 5</xref>. This was as a result of their relative better and significant activity in comparison with the other compounds. Compounds 2 and 5 exhibited a broad spectrum of activity, as a result of their high activity towards all the tested strains. Compound 5 elicited the least minimum inhibitory concentration for all the compounds. This result therefore suggests that low concentrations of this complex may not only inhibit the growth of microorganisms, but also kill them. As a consequence, therefore it suggests that it may have both bacteriostatic and bactericidal effects [<xref ref-type="bibr" rid="scirp.100699-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.100699-ref40">40</xref>].</p></sec></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Coordination compounds of 2-amino-3-methylbutanoic acid and its 1,10-phenantroline and ethylenediamine adducts were synthesized with chromium(III) and oxovanadium(IV) ions. The compounds were investigated for their structural and antibacterial activity. The results obtained suggested an octahedral geometry for all the chromium(III) complexes. A square pyramid geometry was proposed for the bis(2-amino-3-methylbutanoic acid)oxovanadium(IV) complex and the 1,10-phenantroline adduct of oxovanadium(IV). However, an octahedral geometry was proposed for the oxovanadium(IV) ethylenediamine adduct. The antibacterial studies indicated that the 1,10-phenantroline adduct for both oxovanadium(IV) and chromium(III) complexes elicited significant antibacterial activity. They exhibited better activity against the standard, streptomycin, against E. coli and K. pneunoniae. The oxovanadium 1,10-phenantroline adduct also gave the lowest minimum inhibitory concentration for all the tested microbes. This thus suggested that this compound may serve as a lead compound as antibacterial agent against E. coli and K. pneunoniae.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Aiyelabola, T.O., Okunade, I.E., Jordaan, J.H.L. and Otto, D.P. (2020) Syntheses of Coordination Compounds of 2-Amino-3-Methylbutanoic Acid Their Mixed Ligand Complexes and Antibacterial Activities. Advances in Biological Chemistry, 10, 67-85. https://doi.org/10.4236/abc.2020.103006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.100699-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ferell, N.P. (2003) Metal Complexes as Drugs and Chemotherapeutic Agents. In: Comprehensive Coordination Chemistry II, Volume 9, Elsevier, Amsterdam, 809-847.  
https://doi.org/10.1016/B0-08-043748-6/09021-6</mixed-citation></ref><ref id="scirp.100699-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Selvaganapathy, M. and Raman, N. (2016) Pharmacological Activity of a Few Transition Metal Complexes: A Short Review. Journal of Chemical Biology and Therapeutics, 1, 1-10.</mixed-citation></ref><ref id="scirp.100699-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Haas, K.L. and Franz, K.J. (2009) Application of Metal Coordination Chemistry to Explore and Manipulate Cell Biology. Chemical Review, 109, 4921-4960. 
https://doi.org/10.1021/cr900134a</mixed-citation></ref><ref id="scirp.100699-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Anitha, C., Sumathi, S., Tharmaraj, P. and Sheela, C.D. (2011) Synthesis, Characterization, and Biological Activity of Some Transition Metal Complexes Derived from Novel Hydrazone Azo Schiff Base Ligand. International Journal of Inorganic Chemistry, 2011, Article ID: 493942. https://doi.org/10.1155/2011/493942</mixed-citation></ref><ref id="scirp.100699-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Slavin, Y.N., Asnis, J., Hafeli, U.O. and Bach, H. (2017) Metal Nanoparticles: Understanding the Mechanisms Behind Antibacterial Activity. Journal of Nanobiotechnology, 15, 1-20. https://doi.org/10.1186/s12951-017-0308-z</mixed-citation></ref><ref id="scirp.100699-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chohan, Z.H., Farooq, M.A., Scozzafava, A. and Supuran, C.T. (200) Antibacterial Schiff Bases of Oxalyl-Hydrazine; Diamide Incorporating Pyrrolyl and Salicylyl Moieties and of Their Zinc(II). Journal of Enzyme Inhibition and Medicinal Chemistry, 17, 1-7. https://doi.org/10.1080/14756360290005598</mixed-citation></ref><ref id="scirp.100699-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kan, Y.K., Hsu, Y.L., Chen, Y.H., Chen, T.C., Wang, J.Y. and Kuo, P.L. (2013) Gemifloxacin, a Fluoroquinolone Antimicrobial Drug, Inhibits Migration and Invasion of Human Colon Cancer Cells. BioMedical Research International, 2013, 1-11.  
https://doi.org/10.1155/2013/159786</mixed-citation></ref><ref id="scirp.100699-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Patel, R.N., Singh, N., Shukla, K.K., Gundla, V.L.N. and Chauhan, U.K. (2006) Synthesis, Characterization and Biological Activity of Ternary Copper(II) Complexes Containing Polypyridyl Ligands. Spectrochimica Acta, Part A, 63, 21-26. 
https://doi.org/10.1016/j.saa.2005.04.030</mixed-citation></ref><ref id="scirp.100699-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aiyelabola, T., Akinkunmi, E., Obuotor, E., Olawuni, I., Isabirye, D. and Jordaan, J. (2017) Synthesis Characterization and Biological Activities of Coordination Compounds of 4-Hydroxy-3-Nitro-2H-Chromen-2-One and Its Aminoethanoic Acid and Pyrrolidine-2-Carboxylic Acid Mixed Ligand Complexes. Bioinorganic Chemistry and Applications, 2017, Article ID: 6426747. 
https://doi.org/10.1155/2017/6426747</mixed-citation></ref><ref id="scirp.100699-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Efthimiadou, E.K., Katsarou, M.E., Karaliota, A. and Psomas, G. (2008) Copper(II) Complexes with Sparfloxacin and Nitrogen-Donor Heterocyclic Ligands: Structure-Activity Relationship. Journal of Inorganic Biochemistry, 102, 910-920.  
https://doi.org/10.1016/j.jinorgbio.2007.12.011</mixed-citation></ref><ref id="scirp.100699-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Efthimiadou, E.K., Thomadaki, H., Sanakis, Y., Raptopoulou, C.P., Katsaros, N., Scorilas, A., Karaliota, A. and Psomas, G. (2007) Structure and Biological Properties of the Copper(II) Complex with the Quinolone Antibacterial Drug N-Propyl-Norfloxacin and 2,2’-Bipyridine. Journal of Inorganic Biochemistry, 101, 64-73.  
https://doi.org/10.1016/j.jinorgbio.2006.07.019</mixed-citation></ref><ref id="scirp.100699-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Katsarou, M.E., Efthimiadou, E.K., Psomas, G., Karaliota, A. and Vourloumis, D. (2008) Novel Copper(II) Complex of N-Propyl-Norfloxacin and 1,10-Phenan-throline with Enhanced Antileukemic and DNA Nuclease Activities. Journal of Medicinal Chemistry, 51, 470-478. https://doi.org/10.1021/jm7013259</mixed-citation></ref><ref id="scirp.100699-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Dar, O.A., Lone, S.A., Malik, M.A., FM.. Aqualan, Wani, M.Y. and Hashmi, A.A. (2019) Synthesis and Synergistic Studies of Isatin Based Mixed Ligand Complexes as Potential Antifungal Theurapeutic Agent. Heliyon, 5, 1-8. 
https://doi.org/10.1016/j.heliyon.2019.e02055</mixed-citation></ref><ref id="scirp.100699-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sakr, S., Elshafie, H.S., Camele, I. and Sadeek, S.A. (2018) Synthesis, Spectroscopic, and Biological Studies of Mixed Ligand Complexes of Gemifloxacin and Glycine with Zn(II), Sn(II) and Ce(III). Molecules, 23, 1-17. 
https://doi.org/10.3390/molecules23051182</mixed-citation></ref><ref id="scirp.100699-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Malik, M.A., Dar, O.A., Gull, P., Wani, M.Y. and Hashmi, A.A. (2018) Heterocyclic Schiff Base Transition Metal Complexes in Antimicrobial and Anticancer Chemotherapy. Medicinal Chemistry Communication, 1, 409-436.  
https://doi.org/10.1039/C7MD00526A</mixed-citation></ref><ref id="scirp.100699-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Viganar, L., Galdino, A.C.M., Nunes, A.P., et al. (2016) Anti-Pseudomonas Aeruginosa Activity of 1,10-Phenantroline-Based Drugs against Both Planktonic-and Biofilm-Growing Cells. Journal of Antimicrobial Chemotherapy, 71, 128-134.</mixed-citation></ref><ref id="scirp.100699-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Abebe, A. and Hailemariam, T. (2016) Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenan-troline and Guanide. Bioinorganic Chemistry And Applications, 2016, 1-9.  
https://doi.org/10.1155/2016/3607924</mixed-citation></ref><ref id="scirp.100699-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Amani, V., Safari, N., Khavasi, H.R. and Mirzaei, P. (2007). Iron(III) Mixed-Ligand Complexes: Synthesis, Characterization and Crystal Structure Determination of Iron(III) Hetero-Ligand Complexes Containing 1,10-Phenanthroline, 2,2’-Bipyridine, Chloride and Dimethyl Sulfoxide, [Fe(phen) Cl3(DMSO)] and [Fe(bipy)Cl3(DMSO)]. Polyhedron, 26, 4908-4914.  https://doi.org/10.1016/j.poly.2007.06.038</mixed-citation></ref><ref id="scirp.100699-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hogan, D.J. (1990) Allergic Contact Dermatitis to Ethylenediamine. A Continuing Problem. Dermatologic Clinic, 8, 133-136.  
https://doi.org/10.1016/S0733-8635(18)30536-9</mixed-citation></ref><ref id="scirp.100699-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Adkis, A., Benali-Baitich, O., Khan, M.A. and Bouet, G. (2000) Synthesis, Characterization and the Thermal Behavior of Mixed Ligand Complexes of Cobalt(III) with Dimethylglyoxime and Some Amino Acids. Synthesis and Reactions in Inorganic Metals Organometallic and Nanomaterial Chemistry, 30, 1849-1858. 
https://doi.org/10.1080/00945710009351873</mixed-citation></ref><ref id="scirp.100699-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Nomiya, K., Takahashi, S., Noguchi, R., Nemoto, S., Takayama, T. and Oda, M. (2000) Synthesis and Characterization of Water-Soluble Silver(I) Complexes with L-Histidine (H2his) And (S)-(-)-2-Pyrrolidone-5-Carboxylic Acid (H2pyrrld) Showing a Wide Spectrum of Effective Antibacterial and Antifungal Activities. Crystal Structures of Chiral Helical Polymers [Ag(Hhis)]n and {[Ag(Hpyrrld)]2}n in The Solid State. Inorganic Chemistry, 39, 3301-3311. 
https://doi.org/10.1021/ic990526o</mixed-citation></ref><ref id="scirp.100699-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Aiyelabola, T.O., Ojo, I.A. and Akinkunmi, E.O. (2012) Synthesis Characterization and Structural and Antimicrobial Studies of Coordination Compounds of Phenylalanine and Glycine. International Journal of Chemistry, 4, 49-59. 
https://doi.org/10.5539/ijc.v4n2p49</mixed-citation></ref><ref id="scirp.100699-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Pasdar, H., Saghavaz, B.H., Foroughifar, N. and Davallo, M. (2017) Synthesis, Characterization and Antibacterial Activity of Novel 1,3-Diethyl-1,3-Bis(4-Nitro-phenyl)Urea and Its Metal(II) Complexes. Molecules, 22, 1-10.  
https://doi.org/10.3390/molecules22122125</mixed-citation></ref><ref id="scirp.100699-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Kemp, W. (1991) Infrared Spectroscopy. In: Organic Spectroscopy, Macmillan, Hong Kong, 19-98. https://doi.org/10.1007/978-1-349-15203-2_2</mixed-citation></ref><ref id="scirp.100699-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Pavia, D., Lampman, G. and Kriz, G. (2001) Introduction to Spectroscopy. A Guide for Students of Organic Chemistry. 3rd Edition, Brooks and Cole, New York, 22-368.</mixed-citation></ref><ref id="scirp.100699-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Nakamoto, K. (2009) Complexes of Amino Acids. In Infrared and Raman Spectroscopy of Inorganic and Coordination Compounds: Applications In: Coordination, Organometallics and Bioinorganic Chemistry, 6th Edition, John Wiley and Sons, New York, 67-69.</mixed-citation></ref><ref id="scirp.100699-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Bellamy, L.J. (1976) The Infrared Spectra of Complex Molecules. Chapman and Hall, London, United Kingdom, 1-190.</mixed-citation></ref><ref id="scirp.100699-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Greenwood, N.N. and Earnshaw, A. (1997) Coordination Compounds. In: Chemistry of the Elements, 2nd Edition, Oxford, Butterworth-Heinemann, 1060-1090, 1290-1326.</mixed-citation></ref><ref id="scirp.100699-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Pillai, S.I., Subramamian, S.P. and Kandaswamy, A. (2013) A Novel Insulin Mimetic Vanadium-Flavonol Complex: Synthesis, Characterization and the in Vitro Evaluation in STZ-Induced Rat. European Journal of Medicinal Chemistry, 63, 109-117.  
https://doi.org/10.1016/j.ejmech.2013.02.002</mixed-citation></ref><ref id="scirp.100699-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Popp, C.J., Nelson, J.H. and Ragsdale, R.O. (1969) Thermodynamic and Infrared Studies of Tertiary Amine Oxides with Bis(2,4-Pentanedionatooxovanadium(IV). Journal of American Chemical Society, 91, 610-614. 
https://doi.org/10.1021/ja01031a015</mixed-citation></ref><ref id="scirp.100699-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Isabirye, D.A., Naledi, S.H. and Aiyelabola, T.O. (2016) Synthesis and Structural Characterization of Cr(III) Complexes of Porphyrazine and Phthalocyanine Derivatives and the Kinetic Studies of Metalation and Redox Activity. Asian Journal of Chemistry, 29, 489-495. https://doi.org/10.14233/ajchem.2017.20204</mixed-citation></ref><ref id="scirp.100699-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Miessler, G.L. and Tarr, D.A. (1999) Coordination Compounds. In: Inorganic Chemistry, Pearson Prentice Hall, New York, 315-316.</mixed-citation></ref><ref id="scirp.100699-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Pethe, G.B., Yaul, A.R. and Aswar, A. (2011) Synthetic, Characterization and Catalytic Studies of Some Coordination Compounds Derived from Unsymmetrical Quadridentate Schiff Base Ligand Russian. Journal of General Chemistry, 81, 2304-2309.  
https://doi.org/10.1134/S1070363211110144</mixed-citation></ref><ref id="scirp.100699-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Sakurai, H., Katoh, A. and Yoshikawa, Y. (2006) Chemistry and Biochemistry of Insulin-Mimetic Vanadium and Zinc Complexes. Trial for Treatment of Diabetes Mellitus. Bulletin of the Chemical Society of Japan, 79, 1645-1664. 
https://doi.org/10.1246/bcsj.79.1645</mixed-citation></ref><ref id="scirp.100699-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Nejo, A.A., Kolawole, G.A., Opoku, A.R., Muller, C. and Wolowska, J. (2009) Synthesis, Characterization and Insulin-Enhancing Studies of Unsymmetrial Tetradentate Schiff-Base Complexes of Oxovanadium. Journal of Coordination Chemistry, 62, 3411-3424. https://doi.org/10.1080/00958970903104327</mixed-citation></ref><ref id="scirp.100699-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Panchal, P.K., Parekh, H.M., Pansuriya, P.B. and Patel, M.N. (2006) Bactericidal Activity of Different Oxovanadium(IV) Complexes with Schiff Bases and Application of Chelation Theory. Journal of Enzyme Inhibition and Medicinal Chemistry, 21, 203-209. https://doi.org/10.1080/14756360500535229</mixed-citation></ref><ref id="scirp.100699-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Yenikaya, C., Poyraz, M., Sari, M., Demirci, F., Ilkimen, H. and Büyükgüngor, O. (2009). Synthesis, Characterization and Biological Evaluation of a Novel Cu(II) Complex with the Mixed Ligands 2,6-Pyridinedicarboxylic Acid and 2-Aminopy-ridine. Polyhedron, 28, 3526-3532. https://doi.org/10.1016/j.poly.2009.05.079</mixed-citation></ref><ref id="scirp.100699-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Gaelle, D.S., Yufanyi, D.M., Jagan, R. and Agwara, M.O. (2016) Synthesis, Characterization and Antimicrobial Properties of Cobalt(II) and Cobalt(III) Complexes Derived from 1,10-Phenanthroline with Nitrate and Azide Co-Ligands. Cogent Chemistry , 2, Article ID: 1253201. https://doi.org/10.1080/23312009.2016.1253201</mixed-citation></ref><ref id="scirp.100699-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Montazerozohoria, M., Nasr-Esfahania, M., Hoseinpoura M., Naghihab, A. and Zahedia, S. (2014) Synthesis of Some New Antibacterial Active Cadmium and Mercury Complexes of 4-(3-(2-(4-(Dimethyl Aminophenyl Allylidene Aminopropyl-Imino)Prop-1-Ethyl)-N,N-Dimethyl Benzene Amine. Chemical Speciation and Bioavailability, 26, 240-248. https://doi.org/10.3184/095422914X14145135824213</mixed-citation></ref><ref id="scirp.100699-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Páez, P.L., Bazán, C.M., Bongiovanni, M.E., Toneatto, J., Albesa, I., Becerra, M.C. and Argüello, G.A. (2013) Oxidative Stress and Antimicrobial Activity of Chromium(III) and Ruthenium(II) Complexes on Staphylococcus aureus and Escherichia coli. BioMedical Research International, 2013, Article ID: 906912. 
https://doi.org/10.1155/2013/906912</mixed-citation></ref></ref-list></back></article>